Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Response to Supplemental Pentavalent Rotavirus Vaccine at 9 Months in Mali
NCT02286895Phase 4Completed
- Sponsor
- PATH
- Start
- Oct 2014
- Primary completion
- Mar 2015
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of rotavirus vaccine, live, oral, pentavalent in rotavirus infection, sponsored by PATH. Started Oct 2014; status: completed.
02
Drugs
rotavirus vaccine, live, oral, pentavalent
03
Conditions
rotavirus infection
Beyond the preview
Go deeper on NCT02286895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02286895.